ClinicalTrials.Veeva

Menu
C

Cardiology Associates Research Company | Daytona Beach, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bococizumab
Apixaban
BAY 2433334
Finerenone
PB1046
Vericiguat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided hea...

Enrolling
Coronary Artery Disease
Left Ventricular Dysfunction
Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
Device: IABP Intra-aortic balloon pump

Trial sponsors

Bayer logo
Pfizer logo
Abiomed logo
Janssen (J&J Innovative Medicine) logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems